Testing effectiveness (Phase 2)UnknownNCT05268666
What this trial is testing
Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors
Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Jubilant Therapeutics Inc. 126